BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28741179)

  • 1. Activation of liver X receptor inhibits OCT2-mediated organic cation transport in renal proximal tubular cells.
    Wongwan T; Kittayaruksakul S; Asavapanumas N; Chatsudthipong V; Soodvilai S
    Pflugers Arch; 2017 Nov; 469(11):1471-1481. PubMed ID: 28741179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver X receptor activation inhibits SGLT2-mediated glucose transport in human renal proximal tubular cells.
    Chonlaket P; Wongwan T; Soodvilai S
    Exp Physiol; 2018 Feb; 103(2):250-260. PubMed ID: 29127736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver X receptor activation downregulates organic anion transporter 1 (OAT1) in the renal proximal tubule.
    Kittayaruksakul S; Soodvilai S; Asavapanumas N; Muanprasat C; Chatsudthipong V
    Am J Physiol Renal Physiol; 2012 Mar; 302(5):F552-60. PubMed ID: 22169006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Farnesoid X Receptor Activation Stimulates Organic Cations Transport in Human Renal Proximal Tubular Cells.
    Wongwan T; Chatsudthipong V; Soodvilai S
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32846898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenofibrate down-regulates renal OCT2-mediated organic cation transport via PPARα-independent pathways.
    Asavapanumas N; Kittayaruksakul S; Meetam P; Muanprasat C; Chatsudthipong V; Soodvilai S
    Drug Metab Pharmacokinet; 2012; 27(5):513-9. PubMed ID: 22473497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver X receptor agonists decrease ENaC-mediated sodium transport in collecting duct cells.
    Soodvilai S; Jia Z; Fongsupa S; Chatsudthipong V; Yang T
    Am J Physiol Renal Physiol; 2012 Dec; 303(12):F1610-6. PubMed ID: 23077096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
    Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germacrone Reduces Cisplatin-Induced Toxicity of Renal Proximal Tubular Cells via Inhibition of Organic Cation Transporter.
    Soodvilai S; Meetam P; Siangjong L; Chokchaisiri R; Suksamrarn A; Soodvilai S
    Biol Pharm Bull; 2020; 43(11):1693-1698. PubMed ID: 33132314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
    Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N
    Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent effect of liver X receptor agonists on prostate-specific antigen expression is dependent on androgen receptor in prostate carcinoma cells.
    Tsui KH; Chung LC; Feng TH; Lee TY; Chang PL; Chen WT; Juang HH
    Prostate; 2015 May; 75(6):603-15. PubMed ID: 25560459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the Liver X Receptor Pathway Inhibits HBV Replication in Primary Human Hepatocytes.
    Zeng J; Wu D; Hu H; Young JAT; Yan Z; Gao L
    Hepatology; 2020 Dec; 72(6):1935-1948. PubMed ID: 32145089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor.
    Blaschke F; Takata Y; Caglayan E; Collins A; Tontonoz P; Hsueh WA; Tangirala RK
    Circ Res; 2006 Dec; 99(12):e88-99. PubMed ID: 17110595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate-dependent ligand inhibition of the human organic cation transporter OCT2.
    Belzer M; Morales M; Jagadish B; Mash EA; Wright SH
    J Pharmacol Exp Ther; 2013 Aug; 346(2):300-10. PubMed ID: 23709117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LXR agonism improves TNF-α-induced endothelial dysfunction in the absence of its cholesterol-modulating effects.
    Spillmann F; Van Linthout S; Miteva K; Lorenz M; Stangl V; Schultheiss HP; Tschöpe C
    Atherosclerosis; 2014 Jan; 232(1):1-9. PubMed ID: 24401210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic basis of metformin-MPP interactions with organic cation transporter OCT2.
    Sandoval PJ; Morales M; Secomb TW; Wright SH
    Am J Physiol Renal Physiol; 2019 Sep; 317(3):F720-F734. PubMed ID: 31313952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipidomic analysis of human primary hepatocytes following LXR activation with GW3965 identifies AGXT2L1 as a main target associated to changes in phosphatidylethanolamine.
    Santinha D; Klopot A; Marques I; Ellis E; Jorns C; Johansson H; Melo T; Antonson P; Jakobsson T; Félix V; Gustafsson JÅ; Domingues MR; Mode A; Helguero LA
    J Steroid Biochem Mol Biol; 2020 Apr; 198():105558. PubMed ID: 31783151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LXR driven induction of HDL-cholesterol is independent of intestinal cholesterol absorption and ABCA1 protein expression.
    Kannisto K; Gåfvels M; Jiang ZY; Slätis K; Hu X; Jorns C; Steffensen KR; Eggertsen G
    Lipids; 2014 Jan; 49(1):71-83. PubMed ID: 24163219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The multidrug transporter MATE1 sequesters OCs within an intracellular compartment that has no influence on OC secretion in renal proximal tubules.
    Martínez-Guerrero LJ; Evans KK; Dantzler WH; Wright SH
    Am J Physiol Renal Physiol; 2016 Jan; 310(1):F57-67. PubMed ID: 26538438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABCA1 upregulating apolipoproein M expression mediates via the RXR/LXR pathway in HepG2 cells.
    Di D; Wang Z; Liu Y; Luo G; Shi Y; Berggren-Söderlund M; Nilsson-Ehle P; Zhang X; Xu N
    Biochem Biophys Res Commun; 2012 Apr; 421(1):152-6. PubMed ID: 22516753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of MAPK and PKA in regulation of rbOCT2-mediated renal organic cation transport.
    Soodvilai S; Chatsudthipong A; Chatsudthipong V
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F21-7. PubMed ID: 17327500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.